Latest filing published 04 Apr 2023 for Apollo Endosurgery, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Christopher J. Gostout: trading record in brief
Christopher J. Gostout is a declared insider of Apollo Endosurgery, Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 28 February 2018 to 4 April 2023, the count stands at 6 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 4 April 2023 came the latest disclosure, a transaction in Apollo Endosurgery, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher J. Gostout
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 90,267 sharesCommon StockSEC:0001251769-23-000024:0
- 12,920 shares0Common StockSEC:0001251769-22-000014:0
2 of 2 declarations
